 Shelton, Connecticut - September 14, 2019 -- NanoViricides, Inc. NYSE Amer.: NNVC the Company, a global leader in nanomedicines against viruses, announced today that it has completed the process of licensing the human Coronavirus field for drug development and commercialization from TheraCour Pharma, Inc. TheraCour. 